≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm of middle ear and respiratory system

DOID EFO MESH SNOMED PheWeb

CD2_BENIGN_EAR_RESP

cutaneous melanoma: A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D14
Cause of death: ICD-10 D14

2 out of 7 registries used, show all original rules.

1978

diagram downward connector

Check minimum number of events None

1978

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

2354

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

2271

diagram downward connector
CD2_BENIGN_EAR_RESP

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D10-D36
Name in latin Neoplasma benignum auris mediae sive systematis respiratorii

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of middle ear and respiratory system based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 2271 946 1325
Unadjusted prevalence (%) 0.60 0.45 0.80
Mean age at first event (years) 54.80 51.47 57.18

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.89 [1.29, 2.78] 1.2e-3 353
15 years 0.01 1.17 [0.88, 1.57] 2.8e-1 149
5 years 0.00 2.39 [1.85, 3.09] 3.1e-11 100
1 year 0.00 4.13 [2.79, 6.12] 1.5e-12 36

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_EAR_RESP – Benign neoplasm of middle ear and respiratory system
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Benign neoplasm of middle ear and respiratory system
after Benign neoplasm of middle ear and respiratory system

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm of middle ear and respiratory system

↥

Endpoint not on priority list, no data to show.